141 related articles for article (PubMed ID: 12555151)
1. Modulating signaling pathways in hypertrophy and heart failure by gene transfer.
Huq F; Del Monte F; Hajjar RJ
J Card Fail; 2002 Dec; 8(6 Suppl):S389-400. PubMed ID: 12555151
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular assist device-induced molecular changes in the failing myocardium.
Soppa GK; Barton PJ; Terracciano CM; Yacoub MH
Curr Opin Cardiol; 2008 May; 23(3):206-18. PubMed ID: 18382208
[TBL] [Abstract][Full Text] [Related]
3. Ventricular remodeling in heart failure.
Gaballa MA; Goldman S
J Card Fail; 2002 Dec; 8(6 Suppl):S476-85. PubMed ID: 12555161
[TBL] [Abstract][Full Text] [Related]
4. Progression of heart failure was suppressed by inhibition of apoptosis signal-regulating kinase 1 via transcoronary gene transfer.
Hikoso S; Ikeda Y; Yamaguchi O; Takeda T; Higuchi Y; Hirotani S; Kashiwase K; Yamada M; Asahi M; Matsumura Y; Nishida K; Matsuzaki M; Hori M; Otsu K
J Am Coll Cardiol; 2007 Jul; 50(5):453-62. PubMed ID: 17662399
[TBL] [Abstract][Full Text] [Related]
5. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy to inhibit the calcium channel beta subunit: physiological consequences and pathophysiological effects in models of cardiac hypertrophy.
Cingolani E; Ramirez Correa GA; Kizana E; Murata M; Cho HC; Marbán E
Circ Res; 2007 Jul; 101(2):166-75. PubMed ID: 17556655
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer of beta-adrenergic signaling components for heart failure.
Koch WJ
J Card Fail; 2002 Dec; 8(6 Suppl):S526-31. PubMed ID: 12555169
[TBL] [Abstract][Full Text] [Related]
8. [Gene therapy for heart failure].
Ohtsuka M; Komuro I
Nihon Geka Gakkai Zasshi; 2002 Sep; 103(9):611-5. PubMed ID: 12386955
[TBL] [Abstract][Full Text] [Related]
9. [Gene therapy and benefits in modulating of system beta-adrenergic in cardiac insufficiency].
Tevaearai HT; Walton GB; Koch WJ
Rev Med Suisse Romande; 2002 Mar; 122(3):149-53. PubMed ID: 12014253
[TBL] [Abstract][Full Text] [Related]
10. Restoration of beta-adrenergic receptor signaling and contractile function in heart failure by disruption of the betaARK1/phosphoinositide 3-kinase complex.
Perrino C; Naga Prasad SV; Schroder JN; Hata JA; Milano C; Rockman HA
Circulation; 2005 May; 111(20):2579-87. PubMed ID: 15897344
[TBL] [Abstract][Full Text] [Related]
11. Physiological growth synergizes with pathological genes in experimental cardiomyopathy.
Syed F; Odley A; Hahn HS; Brunskill EW; Lynch RA; Marreez Y; Sanbe A; Robbins J; Dorn GW
Circ Res; 2004 Dec; 95(12):1200-6. PubMed ID: 15539635
[TBL] [Abstract][Full Text] [Related]
12. Reversal of calcium cycling defects in advanced heart failure toward molecular therapy.
Hoshijima M; Knöll R; Pashmforoush M; Chien KR
J Am Coll Cardiol; 2006 Nov; 48(9 Suppl 1):A15-23. PubMed ID: 17084280
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
Saccà L; Napoli R; Cittadini A
Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
Chen LL; Yin H; Huang J
Cardiovasc Pathol; 2007; 16(4):221-30. PubMed ID: 17637430
[TBL] [Abstract][Full Text] [Related]
15. Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue.
Pleger ST; Most P; Boucher M; Soltys S; Chuprun JK; Pleger W; Gao E; Dasgupta A; Rengo G; Remppis A; Katus HA; Eckhart AD; Rabinowitz JE; Koch WJ
Circulation; 2007 May; 115(19):2506-15. PubMed ID: 17470693
[TBL] [Abstract][Full Text] [Related]
16. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy in the treatment of heart failure.
Ly H; Kawase Y; Yoneyama R; Hajjar RJ
Physiology (Bethesda); 2007 Apr; 22():81-96. PubMed ID: 17420300
[TBL] [Abstract][Full Text] [Related]
18. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
19. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy.
Jayasankar V; Pirolli TJ; Bish LT; Berry MF; Burdick J; Grand T; Woo YJ
J Mol Cell Cardiol; 2004 Apr; 36(4):531-8. PubMed ID: 15081312
[TBL] [Abstract][Full Text] [Related]
20. Myocyte apoptosis in heart failure.
van Empel VP; Bertrand AT; Hofstra L; Crijns HJ; Doevendans PA; De Windt LJ
Cardiovasc Res; 2005 Jul; 67(1):21-9. PubMed ID: 15896727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
